You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,053,427


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,053,427
Title:Brimonidine gel composition
Abstract: Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
Inventor(s): Buge; Jean-Christophe (Nice, FR), Nadau-Fourcade; Karine (Villeneuve-Loubet, FR), Meunier; Cyril (Mougins, FR)
Assignee: Galderma R&D SNC (Biot, FR)
Application Number:13/158,987
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,053,427
Patent Claims: 1. A topical gel composition, comprising: 0.01 to 5% (w/w) brimonidine; 0.05 to 0.20% (w/w) methylparaben; a second preservative; 0.80 to 1.50% (w/w) a carbomer; 9.0% to 13.0% (w/w) total polyol; and purified water; wherein the topical gel composition has a pH of 4.5 to 7.5; and wherein when the concentration of methylparaben is greater than 0.15% (w/w), the concentration of carbomer is less than 1.25% (w/w).

2. The topical gel composition of claim 1, comprising about 4.5% to 6.5% (w/w) of a first polyol.

3. The topical gel composition of claim 1, further comprising 0.04 to 0.08% (w/w) of a water dispersible form of titanium dioxide.

4. The topical gel composition of claim 1, wherein the carbomer is selected from the group consisting of carbomer 934P, carbomer 974P, and carbomer 980.

5. The topical gel composition of claim 1, wherein the brimonidine is brimonidine tartrate.

6. The topical gel composition of claim 1, wherein the second preservative is selected from the group consisting of sodium benzoate, phenoxyethanol, benzyl alcohol, imidazolidinyl urea, and diazolidinyl urea.

7. A topical gel composition, comprising: 0.1 to 0.6% (w/w) brimonidine tartrate; 0.05 to 0.15% (w/w) methylparaben; a second preservative selected from the group consisting of sodium benzoate, phenoxyethanol, benzyl alcohol, imidazolidinyl urea, and diazolidinyl urea; 0.80 to 1.50% (w/w) carbomer; 4.5 to 6.5% (w/w) propylene glycol; 4.5 to 6.5% (w/w) glycerol; and purified water; wherein the pH of the topical gel composition is adjusted to 5.0 to 6.5 by an adequate amount of sodium hydroxide aqueous solution.

8. The topical gel composition of claim 7, wherein the second preservative is phenoxyethanol, present at an amount greater than 0.3% (w/w) of the total weight of the topical gel composition.

9. The topical gel composition of claim 8, further comprising 0.04 to 0.08% (w/w) of a water dispersible form of titanium dioxide.

10. A method of treating or preventing a skin disorder in a subject, comprising topically administering to a skin area of the subject the topical gel composition of claim 1, wherein the skin area is, or is prone to be, affected by the skin disorder.

11. The method of claim 10, wherein the skin disorder is rosacea, erythema of rosacea, telangiectasia, psoriasis, purpura, erythema of acne, eczema, non-rosacea-related inflammation of the skin, flushing, skin sagging, creasing and/or wrinkling, or a symptom associated therewith.

12. A method of treating or preventing a skin disorder in a subject, comprising topically administering to a skin area of the subject the topical gel composition of claim 7, wherein the skin area is, or is prone to be, affected by the skin disorder.

13. The method of claim 12, wherein the skin disorder is rosacea, erythema of rosacea, telangiectasia, psoriasis, purpura, erythema of acne, eczema, non-rosacea-related inflammation of the skin, flushing, skin sagging, creasing and/or wrinkling, or a symptom associated therewith.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.